Patients’ views will underpin policy decisions, says GPhC

02:53 EST 6 Nov 2013 | Pharmaceutical Journal

The views of patients and their carers will underpin all regulatory policy decisions taken by the General Pharmaceutical Council in the next three years, according to the regulator’s 2014 to 2017 strategic plan published today (5 November 2013). ...

Original Article: Patients’ views will underpin policy decisions, says GPhC

NEXT ARTICLE

More From BioPortfolio on "Patients’ views will underpin policy decisions, says GPhC"

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Pharmacy
Latest News Clinical Trials Research Drugs Reports Corporate
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cardiovascular disease (CVD)
Latest News Clinical Trials Research Drugs Reports Corporate
Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina and heart attack), heart failure, congenital heart disease and stroke. It is also known as heart and circulatory disease. Coron...

Advertisement

Searches Linking to this Story